CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1
about
A pharmacogenomic prospective randomized controlled trial of CYP2B6 polymorphisms and efavirenz dose adjustment among HIV-infected Thai patients: a pilot study.Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.Role of Cytochrome P450 2B6 Pharmacogenomics in Determining Efavirenz-Mediated Central Nervous System Toxicity, Treatment Outcomes, and Dosage Adjustments in Patients with Human Immunodeficiency Virus Infection.
P2860
CYP2B6 18492T->C polymorphism compromises efavirenz concentration in coinfected HIV and tuberculosis patients carrying CYP2B6 haplotype *1/*1
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@ast
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@en
type
label
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@ast
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@en
prefLabel
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@ast
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@en
P2093
P2860
P356
P1476
CYP2B6 18492T->C polymorphism ...... arrying CYP2B6 haplotype *1/*1
@en
P2093
Chonlaphat Sukasem
Samruay Nilkamhang
Sukanya Manosuthi
Supeda Thongyen
Weerawat Manosuthi
P2860
P304
P356
10.1128/AAC.02384-13
P407
P577
2014-02-03T00:00:00Z